Prescription Audits: When the DEA or AG Come Knocking

Anticipating and Responding to Heightened Investigations of Prescribing and Dispensing Practices

A live 90-minute CLE webinar with interactive Q&A

Wednesday, August 22, 2018

1:00pm-2:30pm EDT, 10:00am-11:30am PDT

Early Registration Discount Deadline, Friday, July 27, 2018

or call 1-800-926-7926

This CLE webinar will discuss the increased scrutiny of healthcare providers’ prescribing and dispensing practices by the Drug Enforcement Administration (DEA) and state attorneys general (AG) through their medical boards and other actions, and will guide counsel in preparing for and responding to prescription audits and ensuring ongoing regulatory compliance.


The DEA and state AGs are increasing scrutiny on medical providers at all levels who are involved in prescribing, administering, and/or dispensing controlled substances, especially opiates and other abused drugs. Counsel should prepare providers for DEA or state AG audits and investigations of their practices and to meet varying recordkeeping requirements, including those for prescribing and/or dispensing buprenorphine.

Providers should be aware of the extent to which regulators are “mining” prescribing patterns by reviewing various state prescription drug monitoring programs and used as a basis for further investigation. Investigations also stem from wholesaler reports of suspicious transactions.

Providers with prescription authority must comply with both federal and state drug regulations. Failure to comply—whether negligent or intentional—could result in penalties, including fines, being stripped of the ability to lawfully prescribe, and potential criminal prosecution.

Counsel and providers should understand their potential liability exposure, develop effective policies and procedures, and be prepared to encounter and respond to an audit and to take corrective steps to ensure federal and state law compliance and mitigate damages.

Listen as our authoritative panel of healthcare attorneys discusses current trends in DEA and state AG enforcement of prescribing practices and the audit process. The panel will examine the steps necessary to prepare for an audit and offer best practices to respond when the government comes knocking.



  1. Current trends in prescribing and dispensing enforcement
  2. Audit process
    1. DEA
    2. State AG
  3. Audit preparedness
    1. Maintaining records
    2. Policies and procedures
    3. Risk issues
  4. Responding to an audit


The panel will review these and other crucial issues:

  • What should providers and counsel expect when the DEA or state AG conducts a prescription audit?
  • What policies and procedures should be in place to ensure compliance with federal regulations?
  • What are best practices for counsel to providers facing a DEA or state AG audit?


Rosebush, Lee
Lee H. Rosebush


A registered patent attorney and registered pharmacist, Mr. Rosebush focuses his practice on FDA, regulatory,...  |  Read More

Additional faculty
to be announced.

Live Webinar

Buy Live Webinar
Includes Early Discount Savings of $50 (through 07/27/18)

Live Webinar


Buy Live Webinar & Recording
Includes special savings of $250 (through 07/27/18)

Live Webinar & Download


Live Webinar & DVD

$344 + $9.45 S&H

Other Formats
— Anytime, Anywhere

Includes Early Discount Savings of $50 (through 07/27/18)

Strafford will process CLE credit for one person on each recording. All formats include program handouts. To find out which recorded format will provide the best CLE option, select your state:

CLE On-Demand Video

48 hours after event



48 hours after event



10 business days after event

$247 + $9.45 S&H